Status:
RECRUITING
Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Collaborating Sponsors:
Xi'an Gaoxin Hospital
First Affiliated Hospital of Chongqing Medical University
Conditions:
Coronary Artery Disease
Arrhythmias, Cardiac
Eligibility:
All Genders
3-80 years
Brief Summary
The etiology and specific pathogenesis of many cardiovascular diseases such as coronary atherosclerosis, cardiomyopathy, atrial fibrillation, and stroke are still unclear. Improving diagnosis and trea...
Detailed Description
Cardiovascular and cerebrovascular diseases refer to ischemic and hemorrhagic diseases of the heart, brain and body tissues caused by hyperlipidemia, blood viscosity, atherosclerosis, hypertension, et...
Eligibility Criteria
Inclusion
- Patients who are regularly visited and followed up in the appropriate patient; department.
- All patients met at least one of the following diagnostic criteria for cardiovascular and cerebrovascular diseases:
- coronary artery disease group;
- arrhythmia group;
- heart valve disease group;
- aortic dissection group;
- cardiac masses group;
- myocarditis group;
- hypertension group;
- cardiomyopathy group;
- structural heart disease group;
- ischemic cerebrovascular disease group;
- hemorrhagic cerebrovascular disease group;
- intracranial space occupying lesion group.
Exclusion
- Age \<3 years or \>80 years old;
- Pregnant and lactating women;
- The patient declined to provide informed consent to participate in the study;
- None of the above was met, but the patient was temporarily unable to sign the informed consent form due to coma and other reasons, and no legal representative signed it instead. Depending on the patient's condition, the patient may not be able to regain consciousness and sign the informed consent form.
Key Trial Info
Start Date :
December 5 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
25000 Patients enrolled
Trial Details
Trial ID
NCT06001073
Start Date
December 5 2022
End Date
December 31 2028
Last Update
July 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital of Xian Jiantong University
Xi'an, Shaanxi, China, 710061